Cargando…
Monensin may inhibit melanoma by regulating the selection between differentiation and stemness of melanoma stem cells
Melanoma is the most lethal cutaneous malignancy that threatens human lives. Poor sensitivity to chemotherapy drugs and the high rate of resistance are the bottlenecks of melanoma treatment. Thus, new chemotherapy drugs are needed. Drug repurposing is a safe, economical and timesaving way to explore...
Autores principales: | Xin, Haoran, Li, Jie, Zhang, Hao, Li, Yuhong, Zeng, Shuo, Wang, Zhi, Zhang, Zhihui, Deng, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661142/ https://www.ncbi.nlm.nih.gov/pubmed/31380151 http://dx.doi.org/10.7717/peerj.7354 |
Ejemplares similares
-
Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021) -
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance
por: Liu, Jianglan, et al.
Publicado: (2021) -
Monensin Sensitive 1 Regulates Dendritic Arborization in Drosophila by Modulating Endocytic Flux
por: Harish, Rohit Krishnan, et al.
Publicado: (2019) -
Curcumin plays a synergistic role in combination with HSV-TK/GCV in inhibiting growth of murine B16 melanoma cells and melanoma xenografts
por: Li, Hong, et al.
Publicado: (2019) -
Selective Anti-melanoma Effect of Phosphothioated Aptamer Encapsulated by Neutral Cytidinyl/Cationic Lipids
por: Wu, Jing, et al.
Publicado: (2021)